EPIC1 and colonic neoplasm: To further support Lnc-EPIC1-mediated colon cancer cell progression is due to MYC association, we show that CRISPR/Cas9-inudced MYC KO mimicked Lnc-EPIC1 silencing-induced activity and inhibited colon cancer cell survival, proliferation and migration.